| Q3 2026 |
18 |
$75,744,000 |
— |
— |
— |
BKLN, PHYS, FBTC, CXW, AAAU
|
13F-HR |
16 Nov 2026, 17:28 |
| Q2 2026 |
16 |
$67,312,000 |
— |
— |
— |
BKLN, CXW, PHYS, AAAU, FBTC
|
13F-HR |
11 Aug 2026, 15:48 |
| Q1 2026 |
14 |
$70,624,000 |
— |
— |
— |
BKLN, FBTC, PHYS, CXW, AAAU
|
13F-HR |
14 May 2026, 16:30 |
| Q4 2025 |
13 |
$72,356,000 |
— |
— |
— |
BKLN, FBTC, CXW, PHYS, AAAU
|
13F-HR |
17 Feb 2026, 16:02 |
| Q3 2025 |
14 |
$75,685,000 |
— |
— |
— |
FBTC, BKLN, CXW, PHYS, AAAU
|
13F-HR |
12 Nov 2025, 10:18 |
| Q2 2025 |
13 |
$67,804,000 |
— |
— |
— |
FBTC, BKLN, CXW, PHYS, AAAU
|
13F-HR |
15 Aug 2025, 09:13 |
| Q1 2025 |
12 |
$48,974,000 |
— |
— |
— |
BKLN, CXW, PHYS, FBTC, AAAU
|
13F-HR |
14 May 2025, 11:38 |
| Q4 2024 |
12 |
$48,458,000 |
— |
— |
— |
BKLN, CXW, FBTC, PHYS, AAAU
|
13F-HR |
14 Feb 2025, 10:42 |
| Q3 2024 |
11 |
$40,363,000 |
— |
— |
— |
BKLN, PHYS, CXW, AAAU, META
|
13F-HR |
14 Nov 2024, 17:51 |
| Q2 2024 |
12 |
$39,607,000 |
— |
— |
— |
BKLN, Coherus Biosciences Inc, CXW, PHYS, AAAU
|
13F-HR |
14 Aug 2024, 18:08 |
| Q1 2024 |
12 |
$34,525,000 |
— |
— |
— |
CXW, BKLN, Coherus Biosciences Inc, PHYS, AAAU
|
13F-HR |
10 May 2024, 15:02 |
| Q4 2023 |
11 |
$24,775,000 |
— |
— |
— |
Coherus Biosciences Inc, PHYS, Evolent Health Inc, AAAU, META
|
13F-HR |
12 Feb 2024, 10:48 |
| Q3 2023 |
12 |
$29,484,000 |
— |
— |
— |
Coherus Biosciences Inc, PHYS, Coherus Biosciences Inc, AAAU, META
|
13F-HR |
08 Nov 2023, 16:48 |
| Q2 2023 |
17 |
$36,431,000 |
— |
— |
— |
Coherus Biosciences Inc, PHYS, General Dynamics Corp, AAAU, META
|
13F-HR |
14 Aug 2023, 16:50 |
| Q1 2023 |
17 |
$41,711,000 |
— |
— |
— |
Coherus Biosciences Inc, General Dynamics Corp, AAAU, PHYS, BRY
|
13F-HR |
15 May 2023, 10:49 |
| Q4 2022 |
18 |
$35,596,000 |
— |
— |
— |
Coherus Biosciences Inc, Evolent Health Inc, AAAU, PHYS, MSFT
|
13F-HR |
13 Feb 2023, 18:42 |
| Q3 2022 |
18 |
$46,172,000 |
— |
— |
— |
Coherus Biosciences Inc, Evolent Health Inc, AAAU, CHRD, PDCE
|
13F-HR |
14 Nov 2022, 14:14 |
| Q2 2022 |
22 |
$60,837,000 |
— |
— |
— |
Coherus Biosciences Inc, Evolent Health Inc, CHK, WLL, CEIX
|
13F-HR |
12 Aug 2022, 14:42 |
| Q1 2022 |
34 |
$104,787,000 |
— |
— |
— |
Coherus Biosciences Inc, Evolent Health Inc, CHK, MSFT, GOOG
|
13F-HR |
16 May 2022, 15:10 |
| Q4 2021 |
38 |
$149,344,000 |
— |
— |
— |
Coherus Biosciences Inc, Evolent Health Inc, EXC, EVH, Evolent Health Inc
|
13F-HR |
14 Feb 2022, 15:19 |
| Q3 2021 |
40 |
$185,262,000 |
— |
— |
— |
Coherus Biosciences Inc, Evolent Health Inc, Evolent Health Inc, BCEI, EVH
|
13F-HR |
15 Nov 2021, 12:27 |
| Q2 2021 |
38 |
$166,575,000 |
— |
— |
— |
Coherus Biosciences Inc, Evolent Health Inc, CHRD, EVH, VEI
|
13F-HR |
13 Aug 2021, 11:43 |
| Q1 2021 |
40 |
$136,856,000 |
— |
— |
— |
CHRD, CHK, EVOLENT HEALTH INC, EVOLENT HEALTH INC, VTRS
|
Restatement |
18 May 2021, 11:45 |
| Q4 2020 |
31 |
$81,069,000 |
— |
— |
— |
CHRD, Evolent Health Inc, VTRS, CCI, EVH
|
13F-HR |
16 Feb 2021, 08:54 |
| Q3 2020 |
28 |
$64,460,000 |
— |
— |
— |
Evolent Health Inc, MYL, CCI, EVH, Centene Corp.
|
13F-HR |
16 Nov 2020, 10:31 |